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ABSTRACT: S100B is a dimeric EF-hand protein that
undergoes a calcium-induced conformational change and
exposes a hydrophobic protein-binding surface. Recently
S100B was identified as a binding partner of the dopamine D2
receptor in a bacterial two-hybrid screen involving the third
intracellular loop (IC3). The low in vivo calcium concentration
in bacteria (100−300 nM) suggests this interaction may occur in
the absence of calcium. In this work the calcium-sensitive ability
for S100B to recruit the IC3 of the dopamine D2 receptor was
examined, and regions in both proteins required for complex
formation were identified. Peptide array experiments identified the C-terminal 58 residues of the IC3 (IC3-C58) as the major
interacting site for S100B. These experiments along with pull-down assays showed the IC3 interacts with S100B in the absence
and presence of calcium. 1H−15N HSQC experiments were used to identify residues, primarily in helices III and IV, utilized in
the IC3-C58 interaction. NMR titration data indicated that although an interaction between apo-S100B and IC3-C58 occurs
without calcium, the binding was enhanced more than 100-fold upon calcium binding. Further, it was established that shorter
regions within IC3-C58 comprising its N- and C-terminal halves had diminished binding to Ca2+-S100B and did not display any
observable affinity in the absence of calcium. This indicates that residue or structural components within both regions are
required for optimal interaction with Ca2+-S100B. This work represents the first example of an S100B target that interacts with
both the apo- and calcium-saturated forms of S100B.
T
he S100 family consists of a group of about 25 dimeric,
calcium-signaling proteins. Calcium binding to an S100
protein produces a conformational change that exposes a
hydrophobic surface, allowing recruitment of other proteins
that leads to a biological response. Each S100 protein is
comprised of two EF-hand calcium-binding sites per protomer
connected by a central linker. The first site, formed by helix I a
calcium-binding loop and helix II, has relatively weak calcium
binding ability.
1−3 The second motif contains helix III−loop−
helix IV and has a higher affinity for calcium. The dimeric
nature of the S100 proteins allows them to bind to two or more
target molecules simultaneously. For example, S100B is a well-
characterized member of the family that has been shown to
bind a diverse array of targets, including annexin A6, p53,
RAGE, and NDR kinase.
4−7 In addition, S100B has been
shown to be a biomarker for brain injury
8 and is linked to
neurological diseases such as Parkinson’s and schizophrenia.
9,10
Dopamine D2 receptors are G-protein coupled receptors that
transmit the signal from extracellular dopamine to the
cytoplasm in several neuronal cell types. Downstream targets
affected by dopamine binding to the D2 receptor include
adenylate cyclase,
11 inwardly rectifying potassium channels,
12
and voltage activated N-type calcium channels.
13 Like S100B,
the D2 receptor has been implicated in Parkinson’s disease and
schizophrenia as well as drug addiction. The dopamine D2
receptor contains seven transmembrane domains and has the
ability to dimerize.
14 There are several different types of
dopamine receptor that are classified based on the sequence of
their third cytoplasmic loop (IC3) that connects the membrane
spanning α5 and α6 helices. The dopamine D2 receptor IC3 is
also the main site of interaction for several proteins including
calmodulin
15 and GTP-coupled proteins giving rise to a variety
of signal transduction events.
Calcium dependence is a defining characteristic of S100B
interactions. For example, S100B binds to p53 in a calcium-
dependent manner and inhibits p53 function, promoting cell
survival.
5 The NMR solution structure of Ca2+-S100B with a
bound p53-derived peptide shows the p53 adopts an α-helical
conformation and binds to helices III and IV of S100B along a
flat hydrophobic pocket.
16 This same calcium-dependent
interaction is also observed for NDR kinase
7,17 and TRTK
peptides.
18,19 Recent work identified S100B as a potential
binding partner of the dopamine D2 receptor using a bacterial
two-hybrid assay.
20 This result was surprising as live-cell based
two-hybrid assays typically have not been amenable to the
search for binding partners of calcium-binding proteins.
21 This
caveat is one of the major hurdles in studying calcium-signaling
networks. In the case of the bacterial two-hybrid assay
intracellular free calcium in E. coli is tightly regulated between
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22,23 well below the reported calcium
dissociation constants for S100B (Kd ∼ 20−60 μM) and
most other S100 proteins.
2,3,24 This suggests the interaction
of S100B with the D2 receptor interaction could be calcium
independent. It was also demonstrated that S100B could
enhance D2 receptor downstream events in HEK293 cells,
20
although the role of calcium in this interaction is not yet fully
understood. Resting calcium concentrations in mammalian
cell types are also well below the S100B dissociation
constant for calcium.
25 One suggestion is that S100B
might be required for efficient surface presentation of
receptors, like the dopamine D2 receptor, on the plasma
membrane.
26 In a similar case S100A10 has been shown to
bind to serotonin receptors and annexin A2, allowing them
to be targeted to lipid domains in the plasma membrane.
Interestingly, S100A10 knockout mice display depression
like symptoms, a phenotype linked to problems in the
serotonin-signaling pathway.
27
In this work we used gel filtration, peptide array, and NMR
experiments to understand the mechanisms of interaction
between S100B and the dopamine D2 receptor. In particular,
we examined the ability of calcium to modulate this interaction
and identified the regions on both S100B and the D2 receptor
required for complex formation. The work shows that S100B
binding to the receptor is localized to the C-terminus of the
IC3 loop. Interestingly, there is a clear, albeit weak association
between S100B and the IC3 in the absence of calcium, and this
association is strongly enhanced upon calcium binding to
S100B.
■ EXPERIMENTAL PROCEDURES
Protein Constructs and Purification. Expression and
purification of unlabeled and uniformly 15N-labeled S100B were
completed as described previously.
28,29 The purified protein
was thoroughly dialyzed against multiple changes of EDTA-
containing buffer to remove all calcium, 50 mM KCl, 1 mM
DTT, 5 mM EDTA, pH 8.0. The apo-S100B protein was then
dialyzed into a 3 mM KCl solution at pH 8.0, lyophilized, and
stored at −20 °C.
A construct containing residues R217-Q345 (IC3) from the
D2S dopamine receptor was a generous gift from K. Neve
(Oregon Health and Science University, Portland, OR).
20 This
region, containing the entire IC3 as identified by TM-Finder,
30
was moved into a p11 plasmid (Structural Genomics Consortium-
Toronto) containing a TEV protease cleavable His6 purification
tag. A synthetic gene construct covering residues S288-Q345 of
the D2S receptor (IC3-C58) and containing a TEV protease
cleavable His6 tag was synthesized (DNA 2.0, Menlo Park, CA)
and placed in a pJ404 plasmid under control of the T5 promoter.
Synthetic peptides comprising residues R217-K241 (IC3-N25),
S288-I315 (IC3-M28), and Q316-Q345 (IC3-C30) were
purchased (Biobasic, ON, Canada). Purity of the peptides
(>95%) was confirmed by HPLC and ESI-MS.
His6-IC3 and His6-IC3-C58 proteins were expressed and
purified in identical manners. BL21 DE3 E. coli cells containing
the appropriate construct plasmid were grown in Luria Broth
with ampicillin at 37 °C to an OD600 of 0.6. Protein expression
was induced for 6 h with addition of 1 mM IPTG. Cells were
harvested by centrifugation, and the cell pellet was resuspended
in 50 mM NaH2PO4 and 500 mM NaCl at pH 8.0 (Buffer A).
Cells were lysed using a French pressure cell, and the lysate
was clarified by centrifugation at 38000 rpm for 1 h. The lysate
was then applied to a HiTrap Ni2+ FastFlow column (5 mL)
(G.E. Healthcare, QC, Canada) equilibrated in Buffer A. The
column was washed to a steady baseline with 10 column
volumes of Buffer A supplemented with 62.5 mM imidazole.
Proteins were step eluted with Buffer A containing 250 mM
imidazole. Fractions containing purified proteins were pooled
and TEV protease was added in a 1:100 ratio based on amount
of protein in the pooled fractions. During TEV cleavage the
protein was dialyzed overnight at 4 °C into Buffer A to remove
imidazole. Protein solutions were reapplied to a HiTrap Ni2+
FastFlow column (5 mL) (G.E. Healthcare, QC, Canada), and the
flow-through, containing the cleaved IC3 or IC3-C58 proteins,
was collected. Further protein purification was achieved using a
HiTrap S-HP column (5 mL) (G.E. Healthcare, QC, Canada) and
a linear salt gradient. The final purified proteins were verified by
SDS-PAGE and ESI-MS. From ESI-MS the mass obtained for the
IC3 was 15295.7 ± 0.7 Da, which corresponds closely to the
calculated mass of 15293.5 Da. The mass obtained for IC3-C58
was 6781.9 ± 0.1 Da, which corresponds well to the calculated
mass of 6780.7 Da.
Pull-Down Assays. For pull-down experiments His6-IC3
was exhaustively dialyzed into 50 mM Tris-HCl, 200 mM NaCl,
0.2 mM tris(2-carboxyethyl)phosphine (TCEP) at pH 7.5. All
buffers and protein solutions were treated with Chelex resin to
ensure the complete removal of contaminating calcium. S100B
and IC3 proteins (75 μM) were mixed in a 1:1 ratio (S100B
protomer:IC3) in the presence and absence of 2 mM calcium
and incubated at ambient temperature for 1 h. Ni2+-NTA spin
columns (Qiagen, ON, Canada) were equilibrated in dialysis
buffer prior to addition of the S100B/IC3 mixture (600 μL).
Spin columns were then washed three times with dialysis buffer
and eluted with 600 μL of dialysis buffer supplemented with
500 mM imidazole. Samples were taken of the applied,
unbound, and eluted fractions and run on SDS-PAGE gels,
which were then stained with Coomassie blue dye.
Peptide Array Experiments. Lyophilized S100B protein
(100 μM) was resuspended in 20 mM Tris-HCl and 150 mM
NaCl at pH 7.0 (TBS). Solutions and proteins were
supplemented with either 10 mM EDTA or 1 mM calcium
depending on whether calcium-free (apo) or calcium-saturated
S100B was needed. A G-25 desalting column (10 mL, GE
Healthcare, QC, Canada) was washed with H2O and then
equilibrated in TBS. The column was loaded with S100B (1 mL),
and the two most concentrated fractions (0.5 mL) were pooled for
further experiments. A solution of Alexa-Fluor 680 C2-maleimide
(Invitrogen, ON, Canada) in methanol (5 mM, 100 μL) was
prepared and mixed with 100 μL of TBS. A portion of this
solution (100 μL) was transferred to the pooled S100B protein
solution and gently mixed for 2 h at room temperature. The
solution was passed through a G-25 desalting column; fractions
containing the Alexa-S100B protein were collected and dialyzed
exhaustively into TBS to remove any free Alexa-Fluor 680. The
final concentration of Alexa-S100B was determined using the
Alexa-Fluor 680 extinction coefficient (ε 679 nm = 184000).
Peptide arrays were synthesized by FMOC chemistry using
an Auto-Spot Robot ASP222 (Amimed) on nitrocellulose
membranes.
31,32 Sequential peptides of the IC3 were spotted
on each array membrane. Two arrays, using peptides 18 amino
acid residues in length and stepping through the IC3 sequence
by either one or two residues, were created producing two
nonidentical but overlapping arrays. Each array was washed
with methanol followed by TBS supplemented with 0.05%
Tween-20 (TBS-Tween). Membranes were blocked using either
TBS-Tween with 5% w/v skim milk powder (blocking buffer)
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Canada) in TBS-Tween for apo-S100B experiments, followed
by washing with TBS-Tween. Alexa-S100B (0.05 μM
protomer) was diluted into blocking buffer and incubated
with each array for 2 h at room temperature. In each case, the
solution was removed and the array washed several times with
TBS-Tween. Arrays were imaged using an Odyssey imaging
system (LI-COR, Lincoln, NE).
Gel Filtration Experiments. Purified S100B and IC3-C58
proteins were dialyzed into buffer containing 50 mM Tris-HCl,
150 mM NaCl at pH 7.4. S100B and IC3-C58 were mixed in a 1:1
ratio (50 μM protomer, 500 μL) and supplemented with either
10 mM EDTA or 1 mM CaCl2 for calcium-free or calcium-
saturated experiments. A Superdex G75 analytical gel filtration
column (1 cm × 30 cm) (GE Healthcare, QC, Canada) was
equilibrated with buffer prior to sample injections (500 μL) of the
S100B/IC3-C58 solution. An elution rate of 0.5 mL/min was
maintained, monitored at 280 nm. Since S100B and IC3-C58
proteins absorb poorly at 280 nm, the collected fractions (0.5 mL)
were assessed by SDS-PAGE and stained with Coomassie blue dye.
NMR Titration Experiments of S100B and IC3. All
NMR experiments were performed at 35 °C on a Varian
INOVA 600 MHz spectrometer with pulsed-field gradient
triple resonance probe. Protein solutions were prepared in
50 mM MOPS, 50 mM KCl, 1 mM TCEP, 1 mM DTT, and
5 mM NaN3 at pH 7.0 in 90% H2O/10% D2O using DSS as an
internal reference. In addition, imidazole was added as an
internal pH standard to ensure the sample pH was maintained
during titrations.
33 Samples contained either apo-S100B
(200 μM protomer) or Ca2+-S100B (100 μM protomer).
Ca2+-S100B experiments contained 6 mM calcium chloride.
Apo-S100B experiments used EDTA-treated protein, and all
buffers were treated with Chelex resin (BioRad, ON, Canada)
to remove any free calcium. In all experiments concentrated stocks
of peptides (IC3-C58, IC3-N25, IC3-M28, and IC3-C30) were
made up in the appropriate buffer (with and without calcium),
identical to that of the S100B protein. S100B protein
concentrations were determined by amino acid analysis (The
Hospital for Sick Children-Amino Acid Analysis Facility, Toronto)
done on triplicate samples with peaks corresponding to alanine
and leucine used to calibrate protein concentration.
Titration experiments were monitored using sensitivity-
enhanced 1H−15N HSQC spectra collected for each addition
of peptide.
34 Spectra were collected with 1024 complex points
in the 1H dimension and 64 increments in the 15N dimension.
Data were processed using NMRPipe
35 and analyzed using
NMRViewJ.
36 Titrations were followed using additions of the
appropriate peptide solution until a minimum of 2.0 equiv of
peptide per S100B subunit had been added. In all cases, the
volume of added peptide was less than 10% of the total starting
sample volume (600 μL). The change in chemical shift for
selected peaks in the Ca2+-S100B spectrum with each addition of
peptide was determined as Δδ = [(Δ1H2) + ((Δ 15N/5)2)]1/2.
37
To reduce measurement errors in the relatively small apo-S100B
chemical shifts, only the change in proton chemical shift was used
during fitting. Titration binding data were fit according to the
equation
(1)
where Pt is the total S100B protein concentration, Lt is the total
IC3 ligand peptide concentration, Kd is the dissociation constant,
and N is the maximum chemical shift change upon ligand binding.
A global Kd value was calculated for each peptide titration by
simultaneously fitting the chemical shifts from six different residues
in Ca2+-S100B or ten different residues in apo-S100B to the above
model.
■ RESULTS
In the dopamine receptor family the third cytoplasmic loop
(IC3) defines the receptor subtype and is known to mediate
cytoplasmic protein interactions between the dopamine
receptor and the rest of the signaling pathway. There are two
isoforms of the D2 receptor, which vary by a 29 amino acid
insertion in the IC3, the D2S (short, IC3-129 residues), and the
D2L (long, IC3-158 residues). Both the D2L and D2S variants
of the IC3 have been shown to interact in a similar manner with
S100B,
20 indicating that the insertion in the D2L receptor is
not likely involved in the recognition of S100B. Therefore, for
simplicity the D2S isoform of the IC3 region covering residues
R217-Q345 of the transmembrane receptor was utilized in this
study (Figure 1). Structural information about this region of the
D2 dopamine receptor is not available. The IC3 is highly basic
and has a pI of 11.5. The crystal structure of the closely related
D3 dopamine receptor does not contain electron density in
the region of the IC3, and crystals were obtained only when the
majority of the D3-IC3 was removed.
38 This suggests that the
IC3 is present as a flexible loop and mediates protein
interactions mostly through contiguous stretches in its
sequence.
Apo- and Calcium-Bound S100B Interact with IC3.
The hexahistidine-tagged IC3 (His6-IC3) was expressed and
purified from E. coli for structural analysis and interaction with
S100B. The IC3 yield was low, and the protein was prone to
proteolysis. Nevertheless, a sufficient quantity of purified
protein was obtained to test the interaction between S100B
and the IC3 using a Ni2+ pull-down assay. Given that S100B is a
calcium-binding protein that interacts with its binding partners
in a calcium-dependent manner, the binding of S100B with IC3
was examined in the absence and presence of calcium. His6-IC3
was bound to Ni2+-resin spin columns in the presence of apo-
and Ca2+-S100B. Bound proteins were eluted from the column
and analyzed by SDS-PAGE (Figure 2). His6-IC3 protein was
found to coelute with Ca2+-S100B from the Ni2+ column.
Interestingly, even in the absence of calcium, apo-S100B bound
to His6-IC3, although to a lesser extent than Ca2+-S100B. This
indicates that both apo- and Ca2+-S100B were able to bind with
the IC3 region of the dopamine D2 receptor.
Identification of IC3 Binding Regions with S100B. The
IC3 loop from the dopamine D2 receptor is much larger than
Figure 1. Schematic diagram of the dopamine peptides used for S100B
binding experiments. The amino acid sequence for the third
cytoplasmic loop of the dopamine D2S receptor (IC3) is shown
(R217-Q345). Regions within the IC3 that were expressed from E. coli
or synthesized as peptides are indicated by bars above the protein
sequence near the N-terminus (IC3-N25) and C-terminus (IC3-C58,
IC3-M28, IC3-C30).
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it is likely that a smaller portion of the IC3 is involved in the
interaction with S100B and experiments were conducted to
delineate the interaction site(s) more precisely. To determine
the region of IC3 that binds to S100B peptide array
experiments were conducted using a nested series of 18-residue
sequences linked to a nitrocellulose membrane. The first
peptide of the arrays corresponded to residues R217-A234
of the D2S receptor, the N-terminal 18 residues of the IC3.
Two different arrays were constructed in which subsequent
18-residue peptides continued to step through the IC3 by
either one or two amino acids. Both array types were probed
for binding to either apo-S100B or Ca2+-S100B, labeled with
Alexa-Fluor 680 at position C84, previously shown to be benign
to target protein binding when fluorescently labeled.
39 The
results of the array that stepped through the IC3 region by two
residues at a time (Figure 3) showed that both apo-S100B and
Ca2+-S100B were able to bind to the IC3 region of the D2
receptor. In addition, the pattern of peptides from the IC3 that
bound to apo-S100B and Ca2+-S100B was very similar. These
observations were confirmed with arrays that stepped through
the IC3 sequence by one residue. It is interesting that the
peptide arrays did not show obvious differences in affinity
between apo-S100B and Ca2+-S100B that were observed in the
pull-down experiments. This is likely due to the relatively high
local concentrations of peptide on each spot and the
concentrations of S100B protein needed to visualize a positive
interaction. In combination with the different buffer conditions
used in the apo-S100B and Ca2+-S100B arrays it has been
shown that this makes comparison of spot intensities as a
means for relative affinities difficult.
40
The most intense binding was observed for peptide F1 in
both the apo-S100B and Ca2+-S100B arrays. A closer analysis of
the array data revealed two distinct binding regions in the IC3,
which were selected for further study. The major region
covered the C-terminal 58 amino acids (IC3-C58), denoted by
peptides D6-F7. A second minor region identified from a single
spot (A3) on the arrays included the N-terminal 25 residues of
the IC3 (IC3-N25). A large area comprising residues K241-
S288 (A6-D5) from the IC3 exhibited very little observable
fluorescence for both apo- or Ca2+-S100B, indicating this region
of IC3 is not a major interacting site for S100B. Further analysis
of the IC3-C58 region from the peptide array experiments
showed that it could be subdivided into two smaller regions
demonstrating more intense S100B binding, separated by a
small region with weaker binding (E1-E5). The C-terminal 30
residues of the IC3 (IC3-C30) (E10-F7) and the 28-residue
region adjacent to it (IC3-M28) (D6-E1) peptides split the
IC3-C58 region close to the middle. Because the array
sequences contain overlapping peptides, the region E2-E9 is
represented in both IC3-C30 and IC3-M28 peptides. This
series of four peptides (Figure 1) was used to identify the
binding locations of IC3 on both apo- and Ca2+-S100B as well
as the strength of the interactions.
Disordered IC3-C58 Interacts with S100B. The IC3-
C58 peptide was expressed, purified, and analyzed by circular
dichroism (CD) spectropolarimetry. The resulting spectrum
showed one region of stronger ellipticity near 200 nm, typical
of a disordered protein (data not shown). In addition, a
1H−15N HSQC spectrum collected using 15N-labeled IC3-C58
showed the majority of the peaks were very intense and
collapsed into a small central region centered between 7.1
and 8.0 ppm (1H shifts, data not shown). These data show that
Figure 2. Interaction of IC3 with S100B from affinity chromatography.
The SDS-PAGE gel in the top panel shows His6-IC3 (lanes 1−3) and
apo-S100B (lanes 4−6) loaded on the Ni2+ resin column (lanes 1, 4)
and the wash fraction (lanes 2, 5) followed by elution with excess
imidazole (lanes 3, 6). In the bottom panel purified apo-S100B (lanes
1−3) and Ca2+-S100B (lanes 4−6) were incubated together with His6-
IC3 and applied to Ni2+ resin (lanes 1, 4), washed from the resin as
unbound fractions (lanes 2, 5), and bound protein eluted (lanes 3, 6)
with excess imidazole containing buffer.
Figure 3. Representative peptide arrays of the IC3 regions probed
with S100B. The 129-residue sequence of IC3 was arrayed on
cellulose membranes and probed with fluorescently labeled S100B
in the (A) absence and (B) presence of calcium. These arrays
consist of 18-residue peptides synthesized at each spot on the
membrane and stepping through the IC3 sequence two residues at a
time. The coordinates of each spot on the arrays are identified by
row (A, B, C) and column numbers (1, 2, 3) beside and above the
arrays, respectively. (C) An example of the peptide sequence
progression from spot to spot is shown using the array coordinates
(E7−E10, F1). S100B was fluorescently labeled with Alexa Fluor
680 at position C84 and then used to treat the membranes in the
presence of (A) EDTA or (B) calcium. Red fluorescence is
indicative of bound S100B protein.
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structure.
The formation of complexes between IC3-C58 and both apo-
S100B and Ca2+-S100B was examined using gel filtration
chromatography. Mixtures of S100B and IC3-C58 proteins
were applied to an analytical gel filtration column in the
presence of either EDTA (apo-S100B) or excess CaCl2. Since
S100B and IC3-C58 have poor absorbance characteristics at
280 nm, fractions were collected from the gel filtration column
and examined by SDS-PAGE gel electrophoresis, providing a
clear image of the proteins and potential complexes (Figure 4).
The data showed that S100B, in the absence of IC3-C58, eluted
at an earlier volume than the D2 receptor protein, consistent
with the larger dimeric nature of S100B (21 kDa) compared to
IC3-C58 (6.5 kDa). When the IC3-C58 and Ca2+-S100B
proteins were combined a notable shift to a higher molecular
weight was noted for both proteins consistent with complex
formation between the proteins. In the absence of calcium, a
reproducible shift to higher molecular weight was also observed
although this was not as obvious as with IC3-C58 and Ca2+-
S100B. As with the peptide array experiments, these results
indicate that apo-S100B can interact with the C-terminal 58
residues of the D2 IC3 region. However, the interaction is
considerably stronger upon calcium binding to S100B.
IC3-C58 Binds to Ca2+-S100B with High Affinity. The
peptide array experiments identified distinct regions near the
N-terminus (IC3-N25) and C-terminus (IC3-C58) in the IC3
that interact with S100B. In order to verify these interactions
and determine the strengths of the interactions with S100B,
titrations of the individual peptides with apo- and Ca2+-S100B
were monitored by NMR spectroscopy. These experiments also
allow detailed information about the regions of S100B involved
in the interaction with IC3 to be identified. Figure 5 shows that
in the absence of calcium several residues in S100B underwent
small chemical shift changes (<0.1 ppm) upon addition of
IC3-C58. These included residues V52, K55, V56, M57, and
T59 in helix III and M79, V80, A83, E89, and E91 in helix IV.
All chemical shifts observed were in the fast exchange regime.
Using a global fitting approach for 1:1 binding between
IC3-C58 and an S100B protomer, changes in chemical shift
were fit simultaneously to eq 1 to obtain a Kd of 274 ± 58 μM
(Figure 5C).
Figure 4. Identification of the S100B-IC3 complex by gel filtration.
Bacterially expressed and purified IC3-C58 was preincubated with
either apo-S100B or Ca2+-S100B and loaded on an analytical
Superdex-75 gel filtration column. Eluted fractions were collected
and analyzed by SDS-PAGE gel electrophoresis. The top two panels
show the individual apo-S100B and IC3-C58 proteins. The bottom
two panels show the mixture in the presence of 10 mM EDTA (apo-
S100B) or 1 mM CaCl2 (Ca2+-S100B).
Figure 5. Interaction of IC3-C58 with apo-S100B and Ca2+-S100B identified by NMR spectroscopy. 1H−15N HSQC spectra of (A) 15N-labeled apo-
S100B (200 μM) in the absence (black) and presence (red) of IC3-C58 peptide and (B) Ca2+-S100B (100 μM) in the absence (black) and presence
(red) of IC3-C58 peptide. In both spectra residues affected by the addition of IC3-C58 are labeled. Dotted circles indicate residues that have shifted
from their original positions but could not be located in the S100B-IC3-C58 complex. Chemical shift changes for selected residues in (C) apo-S100B
and (D) Ca2+-S100B plotted as a function of IC3-C58 concentration and globally fit to provide dissociation constants (Kd) of 274 ± 58 and 1 ±
1 μM, respectively.
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C58, titrations between IC3-C58 and Ca2+-S100B led to much
larger chemical shift changes in the 1H−15N HSQC spectra
(Figure 5B). The largest chemical shift changes in Ca2+-S100B
were noted for A9, D12, Q16, and S18 (helix I), V52, V56, and
T59 (helix III), and A75, F76, A78, V80, and A83 (helix IV).
Similar to apo-S100B, the changes in chemical shift for Ca2+-
S100B appeared in the fast or fast-intermediate exchange
regime allowing assignment of Ca2+-S100B bound to IC3-C58
to be completed based on previous assignments.
41 In addition,
all changes in chemical shifts appeared to be linear, suggesting
only a single binding event was occurring (Supporting
Information, Figure S1). Global fitting of the titration data
for several residues found in different regions (helix I, linker,
helices III, IV) of the S100B protein yielded an approximate Kd
near 1 μM for the interaction of IC3-C58 with each Ca2+-
S100B protomer (Figure 5D). This indicates that the affinity
for IC3-C58 is ∼300-fold higher for Ca2+-S100B compared to
apo-S100B.
Titrations of IC3-N25 into either apo-S100B or Ca2+-S100B
resulted in no significant changes in the 1H−15N HSQC spectra
(data not shown). Although peptide array experiments were
suggestive of an interaction with S100B the titration indicates
that the affinity is very weak. It is important to note that only a
single peptide spot displayed observable binding in the IC3-
N25 region of peptide arrays (for example, Figure 3), even with
a large excess of free S100B used in the array experiments, while
large contiguous peptide regions were observed for IC3-C58
binding to S100B. These results indicate that the C-terminal
portion of the IC3 for the dopamine D2 receptor is the major
site of interaction with S100B, and this interaction is
accentuated upon calcium binding to the S100 protein.
Evidence for Multiple Binding Regions in IC3 for Ca2+-
S100B. Structures of different S100 proteins bound to
peptides representing protein target-binding regions vary
from 12 (TRTK-12) to 30 (Siah1-interacting protein, SIP)
residues.
18,42 At 58 residues, the IC3-C58 region would,
therefore, be considered an unusually large S100B binding
region. Since peptide array experiments suggested two separate
binding areas (IC3-M28, IC3-C30) might exist within the IC3-
C58 region, we used peptides for both regions (Figure 1) to
determine how these might contribute to binding with S100B.
In both cases, no significant chemical shift changes were
observed in apo-S100B despite addition of excess IC3-M28 or
IC3-C30 peptides (data not shown).
The titration of IC3-M28 to Ca2+-S100B showed several
changes in the 1H−15N HSQC spectrum (Figure 6A and
Supporting Information Figure S2) although in general the
magnitude of the chemical shift changes were smaller than
observed for IC3-C58. Titrations with the IC3-C30 peptide and
Ca2+-S100B produced very similar results (Figure 6B and
Supporting Information Figure S3). Interestingly many of the
affected residues in Ca2+-S100B were the same for both IC3-
C30 and IC3-M28 peptides including A9, D12, S41, V56, A78,
A83, and C84. The chemical shift changes for multiple residues
in each of these peptides were globally fit to determine
dissociation constants of ∼98 and ∼148 μM for binding of IC3-
C30 and IC3-M28, respectively, to Ca2+-S100B (Figure 6).
Figure 6. Interaction of IC3-M28 and IC3-C30 with Ca2+-S100B identified by NMR spectroscopy. 1H−15N HSQC spectra of 15N-labeled Ca2+-
S100B (100 μM) in the absence (black) and presence (red) of (A) IC3-M28 and (B) IC3-C30 peptides. Residues most affected by the addition of
the IC3 peptides are labeled. Dotted circles indicate residues that have shifted from their original positions but could not be located in the S100B−
peptide complex. Chemical shift changes (Δδ) for indicated residues in Ca2+-S100B were plotted as a function of (C) IC3-M28 and (D) IC3-C30
concentrations. Global fitting was completed for 1:1 binding using the residues indicated between each peptide and the S100 protomer as described
in the Experimental Procedures section. This yielded dissociation constants (Kd) of 149 ± 26 μM for IC3-M28 and 98 ± 12 μM for IC3-C30.
Attempts to fit the data for 2:1 binding (2 peptides per protomer) yielded similar results with larger errors.
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observed for IC3-C58. Since the overall trends for residues that
shifted in Ca2+-S100B were very similar for IC3-C58 and its
subpeptides IC3-M28 and IC3-C30 (Supporting Information
Figure S4), attempts were also made to fit the data for 2:1
stoichiometry (i.e., two IC3-M28 peptides to each Ca2+-S100B
protomer) assuming that each peptide might bind to two
different regions akin to the intact IC3-C58 peptide. Attempts
to fit to this model yielded similar affinities with poor fits and
large errors likely a result of the overall weak affinity of these
individual peptides for Ca2+-S100B. Nevertheless, the low
affinity of IC3-M28 and IC3-C30 suggest that regions within
both peptides contribute to the higher affinity binding of IC3-
C58.
Identification of the IC3 Binding Surface on S100B. The
magnitudes of the chemical shift changes for binding of IC3-
C58 to Ca2+-S100B and apo-S100B were used to identify the
surface of interaction for the IC3 with S100B (Figure 7). For
apo-S100B the only contiguous area of residues experiencing
relatively large chemical shift changes was located on helices III
and IV. However, several of these residues are not surface
accessible in the apo-S100B structure including V52, V56, F76,
V80, and A83. It may be possible that apo-S100B is undergoing
a ligand-induced conformational change upon presentation
of IC3-C58, a finding noted previously for the interaction of
apo-calmodulin with the cardiac sodium channel NaV1.5
43 or
myosin.
44 The discontinuity of the surface for IC3-C58 binding
to apo-S100B is in agreement with the lower binding affinity
observed.
The interaction of IC3-C58 with Ca2+-S100B shows a
contiguous interaction surface is formed at the junction of
helices III and IV of S100B, typical for many S100 target−
protein interactions. Some of these residues, including V56
(helix III) and F76, M79, V80, A83, and E89 (helix IV), were
also affected in apo-S100B upon IC3-C58 interaction. In
addition, there is a smaller region of interaction on the opposite
face of Ca2+-S100B, running along the solvent exposed side of
helix I composed of residues A9, I11, D12, and Q16. This
region on helix I is found in each of the Ca2+-S100B IC3-
peptide titrations (IC3-C58, IC3-C30, IC3-M28) and is similar
to a binding surface found on Ca2+-S100A6 for Siah 1
interacting protein (SIP) binding.
42 The two distinct regions
of chemical shift changes on Ca2+-S100B may indicate that IC3
utilizes two binding sites.
■ DISCUSSION
Characterization of S100B-IC3 Binding. A variety of
three-dimensional structures have shown that calcium-binding
to most S100 proteins results in a conformational change that
exposes a hydrophobic binding pocket used to recruit target
protein partners.
16,17,29,42,45,46 Although S100B has been
observed to interact with a wide variety of proteins, most of
these have been identified from in vitro experiments. In vivo
interactions derived from two-hybrid or co-immunoprecipita-
tion experiments tend to work poorly for S100B and most
other EF-hand containing proteins due to the calcium-binding
requirement.
21 The recent identification of the dopamine D2
receptor as an S100B target protein using a bacterial two-hybrid
assay
20 presents one of the first cases where a binding partner
for S100B has been identified using these methods. Since
intracellular free calcium is tightly regulated near 100−300 nM
in E. coli
22,23 and 100−200 nM in humans,
25 well below the
calcium dissociation constants for most S100 proteins, this
suggested that S100B might be interacting with the dopamine
D2 receptor in the calcium-free state.
Peptide array, gel filtration, and NMR titration experiments
identified the C-terminal portion of the dopamine D2 receptor
IC3 loop (IC3-C58) as the major interacting site with both
apo- or Ca2+-S100B. Sequence alignments of IC3-C58 with
S100B binding sequences from p53, NDR kinase, and TRTK-
12 showed there are no clear sequence similarities in any of
these peptides other than a basic pI and several hydrophobic
residues in the sequences. A TRTK consensus sequence
18,47 at
the N-terminus of the IC3
20 is apparent, although this region
(IC3-N25) showed little binding to S100B. This observation is
consistent with the ability of S100B to bind multiple, diverse
targets with little sequence similarity.
A Unique Interaction of IC3 with Apo-S100B. The
affinity of the interaction between apo-S100B and the IC3-C58
region of the dopamine D2 receptor was ∼274 μM. This
binding affinity is similar to those measured for some other
apo- and Ca2+-S100 protein interactions including apo-S100A4
and F-actin (∼550 μM),
48 apo-S100P and melittin (residues
1−26, ∼200 μM),
49 apo-S100A12 and the receptor for
advanced glycated end-products (RAGE) (residues 129−336,
∼140 μM),
50 Ca2+-S100B with the N-terminus of p53 (residues 1−
29, Kd ∼ 76 μM), and Ca2+-S100A2 with p53 (residues 362−393,
Kd ∼ 106 μM).
51 In addition, several well-studied protein−protein
interactions have been identified for calmodulin, an EF-hand
Figure 7. Potential binding surfaces for the IC3 region of the dopamine D2 receptor mapped to the surfaces of apo-S100B and Ca2+-S100B. Residues
in the dimeric structures of (A) apo-S100B (2PRU)
67 and (B) Ca2+-S100B (1MQ1)
29 that shifted more than 0.25 standard deviations above the
average chemical shift change in IC3-C58 titrations are indicated in different shades of red to denote the two protomers in the S100B dimer. Only
residues for one protomer are labeled.
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state often binds to proteins that contain short IQ motifs
(consensus − (I/L/V)Q(X)3R(X)4(R/K), X = any residue).
52
These apo-calmodulin interactions include an IQ motif in
neurogranin (Kd ∼ 60 μM),
53 the IQ motif in Purkinje cell
protein 4 (PEP-19) (Kd ∼13 μM),
54 and the IQ motif from the
cardiac sodium channel NaV1.5 (∼0.2 μM).
55 The solution
structure of CaM bound to the NaV1.5 IQ motif
43 reveals that
IQ binding has partially opened the CaM binding site to an
intermediate position and the IQ motif has moved into the
hydrophobic binding pocket. This ligand induced conformational
change may also be occurring when IC3-C58 binds to apo-S100B,
as indicated by the chemical shift changes of buried residues,
particularly in helices III and IV. A search of the D2-IC3 sequence
did not reveal any obvious sequence similarity to the IQ motif.
These observations indicate that the dopamine D2 receptor likely
interacts with apo-S100B in a unique manner from the IQ motif
interaction with calmodulin and support a calcium-free recruitment
suggested from bacterial two-hybrid experiments.
20
Calcium Enhancement of IC3 Binding to S100B. Gel
filtration and NMR experiments indicated that calcium-binding
to S100B leads to an ∼300-fold increase in affinity for IC3-C58
compared to the apo-state. The affinity (Kd ∼ 1 μM) is similar
to interactions of Ca2+-S100B with SIP (Kd ∼ 5 μM),
42 TRTK-
12 (Kd ∼ 0.3 μM),
56 myelin-associated glycoprotein (Kd ∼ 7
μM),
57 and guanylate cyclase (Kd ∼ 2 μM).
58 Separation of
IC3-C58 into two smaller regions, IC3-C30 and IC3-M28,
reduces this binding by ∼100-fold, indicating that at least a
portion of each of these regions is required for optimal
interaction. This observation is similar to that observed by Lee
and co-workers for the interaction of Ca2+-S100A6 with the
C-terminus of SIP.
42 In this structure, SIP forms a tandem two-
helix arrangement where one helix (helix A) binds in the
hydrophobic surface between helix III and helix IV of Ca2+-
S100A6, while the second helix (helix B) makes contacts with
helix I on the opposite face of S100A6. Both helices of SIP are
needed for maximal binding since helix A shows reduced
binding to Ca2+-S100A6 and helix B does not have any
observable binding. The surface of Ca2+-S100B displays similar
features as SIP for the interaction with IC3-C58 having the
largest changes in chemical shift near helices I, III, and IV. This
ability of Ca2+-S100B to function in complex formation with
more than one protein region may also be important for the
recruitment of multiple target proteins. For example, S100A10
and S100A11 can bind annexin A1 and A2 in combination with
membrane spanning proteins dysferlin, NS3, or TASK-1 to
function in membrane repair.
59−62 The current observations
suggest that the S100B interaction with the dopamine D2
receptor may fall into this class of S100 binding.
The recognition of the IC3 loop from the dopamine D2
receptor by apo-S100B may represent a new type of calcium-
insensitive target interaction for an S100 protein. For dopamine
signaling this association may provide an rapid response to
calcium and enhanced formation of the S100B-IC3 complex.
For example, it has been shown that the calcium affinities of
S100B
2,3 and S100A1
63,64 can be increased in the presence of a
target protein. Alternatively, it is possible that calcium binding
to S100B results in inactivation of the dopamine receptor
through altered binding since S100B can increase D2 receptor
stimulation of the dopamine-signaling pathway in HEK293
cells
20 at resting calcium concentrations. This idea fits well with
the observation that calcium-activated calmodulin can interact
with the IC3-N25 region of the dopamine D2 receptor,
resulting in reduced signaling.
15 Calcium is also known to
reduce intracellular cAMP, which is normally up-regulated
when dopamine binds to the D2 receptor, by inhibiting adenyl
cyclase type V and activating CaM-sensitive phosphodies-
terases.
65,66 The current work identifies the region of the
dopamine D2 receptor recruited by both apo- and Ca2+-S100B
and paves the way for future biochemical studies to elucidate
the mechanism of these interactions in the signaling pathway.
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